Systematic dynamic susceptibility contrast (DSC) perfusion analysis in tumor tissue by MRI confirmed that sunitinib‐treated NeuT;Apln−/− tumors have the lowest vessel permeability (Fig 5B and C). This evidence concerns the gene APLN and neoplasm.